Spatial multi-omics analysis of the microenvironment in traumatic spinal cord injury: a narrative review

Frontiers in Immunology, 2024 · DOI: 10.3389/fimmu.2024.1432841 · Published: August 29, 2024

Simple Explanation

Traumatic spinal cord injury (tSCI) leads to a local microenvironmental imbalance in the spinal cord, including accumulation of cytokines and chemokines, reduced angiogenesis, dysregulation of cellular energy metabolism, and dysfunction of immune cells at the site of injury, which severely impedes neurological recovery from spinal cord injury (SCI). Spatial multi-omics technology combines data from immunohistochemistry and multiparametric analysis to reveal the changes in the microenvironment at different times of secondary injury after SCI. The review systematically examines the progress of spatial multi-omics techniques in studying the microenvironment after SCI, covering changes in the immune microenvironment and potential future therapeutic strategies.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Level 5, Narrative Review

Key Findings

  • 1
    Single-cell RNA sequencing (scRNA-seq) has advanced understanding of the pathophysiology of spinal cord injury, offering insights into new cell types/subtypes, neuroimmunology, biological states, and their activation.
  • 2
    Spatial transcriptomics using in situ hybridization (ISH) and in situ sequencing (ISS) allows for the spatial information of cells to be explored, preserving the spatial information of the sample by bypassing tissue dissociation.
  • 3
    Spatial multi-omics technologies are now widely used to study the transcriptome, proteome, and metabolome of the immune microenvironment of spinal cord injury, enabling new insights into the interactions between intracellular and inter-cellular molecular mechanisms.

Research Summary

This review explores the use of spatial multi-omics technologies to understand the microenvironment after traumatic spinal cord injury (tSCI). The pathological mechanism of traumatic spinal cord injury (tSCI) can be divided into primary and secondary injuries based on their pathological process. Single-cell techniques like scRNA-seq reveal cellular heterogeneity, but spatial information is lost. Spatial multi-omics integrates immunohistochemistry and multiparametric analysis to show microenvironmental changes at different times of secondary injury after SCI. The review highlights neuronal, astrocyte, microglia, oligodendrocyte, and peripheral immune cell dynamics after SCI, along with scar and vascular heterogeneity. Proteomics and metabolomics studies provide molecular signatures associated with changes in physiological systems, aiding in the identification of therapeutic targets.

Practical Implications

Precision Medicine

Spatial multi-omics enables precision medicine and personalized treatment strategies for spinal cord injury.

Biomarker Discovery

Spatial transcriptomics has the potential to discover new cellular biomarkers, such as Glmp and Nfe2l2, which are DAM-specific transcription factors in SCI.

Therapeutic Mechanism Insights

Spatial multi-omics may reveal the mechanism of promoting SCI repair based on biomaterials such as scaffolds and hydrogels, aiding in the design of better therapeutic interventions.

Study Limitations

  • 1
    Most current studies are based on a single omics approach, limiting comprehensive understanding.
  • 2
    Human spinal cord development is unique compared to rodents, leading to differences in spatiotemporal gene expression that can affect translation of animal study results.
  • 3
    Significant temporal differences exist between mice and rats, potentially complicating the interpretation of experimental results across different animal models.

Your Feedback

Was this summary helpful?